
Telmikinz-CT Tablet
Marketer
Henin Lukinz Pvt Ltd
Salt Composition
Telmisartan (40mg) + Chlorthalidone (12.5mg)
Overview Telmikinz-CT Tablet
Telmikinz-CT tablets combine two active ingredients, both effective in managing hypertension. This blood pressure reduction lowers your future risk of stroke and heart attack. Consumption is independent of meals. Dosage is individualized based on your response and health status; consistent daily timing is recommended. Continue treatment as directed by your physician. The diuretic component increases urination; therefore, avoid doses within four hours of bedtime. Regular use maximizes therapeutic benefits, even in the absence of noticeable symptoms (as hypertension is often asymptomatic). Discontinuing treatment elevates stroke and heart attack risk. Dizziness is the most frequent side effect; others include nausea, diarrhea, headache, and altered lipid profiles. Increased urination is an intended effect of the chlorthalidone component and contributes to blood pressure control, not a side effect. While less common, other side effects are possible. Consult the patient information leaflet and inform your doctor about persistent or bothersome side effects; dosage adjustment or alternative medication may be considered. Avoid use during pregnancy, and consult your doctor before taking this medication if you have kidney or liver disease, cardiac issues, or diabetes. Alcohol consumption may exacerbate blood pressure lowering and increase side effect risk.
Uses of Telmikinz-CT Tablet
Elevated arterial blood pressure
Major Benefits of Telmikinz-CT Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Telmikinz-CT Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Telmikinz-CT Tablet:
- Dizziness
- Back pain
- Sinus infection
- Diarrhea
- Red spots or bumps
- Decreased potassium level in blood
- Increased uric acid level in blood
- Postural hypertension (high blood pressure)
- Impotence
- Loss of appetite
- Gastrointestinal disturbance
How to use Telmikinz-CT Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Telmikinz-CT Tablets can be administered with or without food, though consistent timing is recommended.
How Telmikinz-CT Tablet works:
Telmikinz-CT tablets contain a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Telmikinz-CT Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Telmikinz-CT tablets during pregnancy poses a confirmed risk to the fetus. While generally inadvisable, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the inherent dangers. Always seek medical advice.
Breast feedingUNSAFE
Use of Telmikinz-CT Tablets is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Taking Telmikinz-CT Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmikinz-CT Tablets, as dose modification may be necessary. Such patients should seek medical advice before taking this medication; its use is generally discouraged in this population.
LiverCAUTION
Patients with liver impairment should use Telmikinz-CT Tablets cautiously, potentially requiring dosage modification under medical supervision. The use of Telmikinz-CT Tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Telmikinz-CT Tablet :
Should you forget a Telmikinz-CT Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmikinz-CT Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |
